Tag: leukemia

Marshall A. Lichtman, M.D., a University of Rochester hematologist/oncologist and former dean of the School of Medicine and Dentistry, will receive one of the highest honors in his field from the ...

Leukemia is one of the hardest cancers to treat, but scientists have discovered a new, targetable pathway in one of the worst subtypes of the disease.

A clinician/scientist, who studies ways to make cord-blood transplants for leukemia and lymphoma patients safer and more effective, recently reported a new finding in the journal, Blood. An ...

A recent study by University of Rochester Medical Center researchers proves why leukemia is so difficult to treat and suggests that the current approach to drug development should be adjusted to ...

The Blood and Marrow Transplant (BMT) Program at UR Medicine’s Wilmot Cancer Institute recently performed its 3,000th transplant. The program, which opened in 1989, treats both adults and children ...

Rare diseases affect approximately 25 million people in the U.S., but less than 5 percent of these illnesses have a treatment. With the help of patients and their families, physicians and scientists ...

Wilmot Cancer Institute investigators have shown direct evidence of how changes in the blood-cell manufacturing environment can cause cells to malfunction and turn cancerous. The research, reported ...

Older adults with chronic lymphocytic leukemia may now have an alternative to toxic chemotherapy as their first treatment, according to a national study co-authored by a UR Medicine Wilmot Cancer ...

Researchers at UR Medicine’s Wilmot Cancer Institute have developed what they believe to be the first mouse model to investigate why a certain subset of acute myeloid leukemia (AML) patients responds ...

The Blood and Marrow Transplant (BMT) Program at UR Medicine’s Wilmot Cancer Institute was recognized for its high level of care and detailed quality management processes with a three-year ...